Responses
Clinical and epidemiological research
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
Compose a Response to This Article
Other responses
No responses have been published for this article.